Compare Novavax Inc (NVAX) vs Otis Worldwide Corp (OTIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Otis Worldwide Corp — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Otis Worldwide Corp trades at $72.17 (market cap $28.20B). The key difference: Otis Worldwide Corp is far larger — about 21.7× Novavax Inc's market cap, and Otis Worldwide Corp pays a 2.31% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | OTIS | |
|---|---|---|
Market Cap | $1.30B | $28.20B |
Sector | Health | Industrials |
52-Week High | $11.19 | $100.99 |
52-Week Low | $6.22 | $69.34 |
Enterprise Value | $800.50M | $35.58B |
Dividend Yield | — | 2.31% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Otis Worldwide Corp
Otis is the largest global elevator and escalator supplier by revenue with around one quarter of share excluding Japan. In 1854 Otis' founder and namesake, Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed.The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15-20 year useful life of an elevator. As the largest global OEM, over decades Otis has built a base of 2 million elevators under service. Its business model is much the same as that of its competitors Kone, Schindler, and Thyssenkrupp.
Read more on OTIS →
